Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordCe document a été mis à jour. Il ne s’agit pas de la dernière version publiée. Cliquez ici pour voir la dernière version du fichier.
Organisme vivant modifié
(LMO)
L’image ci-dessous identifie l’OVM par son identificateur unique, son nom commercial et un lien vers cette page du Centre d’échange Cliquer dessus pour télécharger une plus grande image sur votre ordinateur Pour du soutien sur comment utiliser, aller dans la page de liens rapides OVM.
VECTORMUNE® FP MG Vaccine
EN
FP MG
Non
-
Personne :Dr Alexis Henry Gaetan GouxPresident of CIBio,Rua Manuel Joaquim Filho, 303 Pulínia - SPPaulínia, São Paulo
13140-000, BrésilTéléphone : 551938337700,Télécopieur : 55193833-7722,E-mail : alexisgoux@ceva.com,Site Web : http://www.ceva.com.br/,Organisations reliéesCeva Saúde Animal Ltda (CEVA)Rua Manuel Joaquim Filho, 303 Pulínia - SPPaulínia, São Paulo
13140-000, BrésilTéléphone : 551938337700,Télécopieur : 55193833-7722,E-mail : alexisgoux@ceva.com,Site Web : http://www.ceva.com.br/,
VECTORMUNE® FP MG is a genetically engineered live virus vaccine for the vaccination of chickens as an aid in the prevention of fowl pox and Mycoplasma gallisepticum. The fowl pox vaccine has been genetically engineered to contain and express key protective Mycoplasma gallisepticum bacterial antigens.
EN
Le terme « organisme récepteur » désigne un organisme (non modifié ou déjà modifié) ayant fait l'objet d'une modification génétique, tandis que les « organismes parentaux » désignent les organismes impliqués dans un croisement ou une fusion cellulaire pour générer un organisme modifié.
-
BCH-ORGA-SCBD-105171-4 Organisme Fowlpox virus (FOWPV)Virus
FR
pUC18
EN
- (Homologous Recombination)
Certains de ces éléments génétiques peuvent être présents sous forme de fragments ou sous forme tronquée. Veuillez consulter les notes ci-dessous, s’il y a lieu.
-
BCH-GENE-SCBD-105360-1 mgc3 gene | Mycoplasma gallisepticum (MG, MYCGL)Séquence codante de protéines | Production de composés médicaux ou pharmaceutiques (humains ou animaux) (Vaccins)
-
BCH-GENE-SCBD-105411-1 MG 40k antigen gene | Mycoplasma gallisepticum (MG, MYCGL)Séquence codante de protéines | Production de composés médicaux ou pharmaceutiques (humains ou animaux) (Vaccins)
A 3kb Hpal-Spel fragment of the FPV genome was inserted into a EcoR1-HindIII site of a pUC18 vector. The homologous recombination site may be interrupting a possible open reading frame but is thought to be non-essential for viral replication and has no known function in the FPV.
A 175bp EcoRV fragment of the FPV genome was removed from this construct and replaced with the MG 40K and mcg3 coding sequences.
Regulatory sequences were also inserted into the vector. The MG 40K and mcg3 genes were each coupled with a synthetic Ps promoter, which emulates the consensus early/late promoter of poxvirus. A termination sequence derived from the gB gene of the Marek Disease Virus was also inserted into the pUC18 vector.
Furthermore, a MDV gB transit signal sequence was added to the 3' terminus of the of MG 40K and mcg3 coding sequences to ensure localisation to the cell membrane.
This construct and the attenuated parental FPV strain were co-transformed into chicken embryo fibroblasts (CEF) and incubated under conditions that favour homologous recombination.
After transfection, viral particles were cultivated from the chicken embryo fibroblasts and assayed for expression of MG 40K and mcg3 proteins. Plaques expressing MG 40K and mcg3 proteins were isolated and selected until the pure recombined virus was obtained.
EN
A 175bp EcoRV fragment of the FPV genome was removed from this construct and replaced with the MG 40K and mcg3 coding sequences.
Regulatory sequences were also inserted into the vector. The MG 40K and mcg3 genes were each coupled with a synthetic Ps promoter, which emulates the consensus early/late promoter of poxvirus. A termination sequence derived from the gB gene of the Marek Disease Virus was also inserted into the pUC18 vector.
Furthermore, a MDV gB transit signal sequence was added to the 3' terminus of the of MG 40K and mcg3 coding sequences to ensure localisation to the cell membrane.
This construct and the attenuated parental FPV strain were co-transformed into chicken embryo fibroblasts (CEF) and incubated under conditions that favour homologous recombination.
After transfection, viral particles were cultivated from the chicken embryo fibroblasts and assayed for expression of MG 40K and mcg3 proteins. Plaques expressing MG 40K and mcg3 proteins were isolated and selected until the pure recombined virus was obtained.
FR
- Vaccin
FR
FR
- Vectormune® FP-MG - Biomune Company [ English ]
- Vectormune® FP-MG - CTNBio [ English ]
- A safety assessment of a fowlpox-vectored Mycoplasma gallisepticum vaccine in chickens [ English ]
| Type de fichier | Champs | Fichier(s) : | |
|---|---|---|---|
| Organisme vivant modifié | Organisme récepteur ou organismes parentaux | 1 | |
| Organisme vivant modifié | Related LMO(s) | 1 | |
| Décision de pays ou tout autre communication | Identification de l'OVM | 2 | |
| Évaluation des risques générée par un processus de réglementation | Organisme(s) vivant(s) modifié(s) | 1 | |